BlackRock Institutional Trust’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$4.99M Hold
398,499
﹤0.01% 2730
2016
Q3
$5.52M Buy
398,499
+45,793
+13% +$519K ﹤0.01% 2650
2016
Q2
$3.48M Buy
352,706
+21,756
+7% +$361K ﹤0.01% 2834
2016
Q1
$5.6M Buy
330,950
+4,471
+1% +$71.9K ﹤0.01% 2594
2015
Q4
$7.27M Buy
326,479
+6,307
+2% +$159K ﹤0.01% 2518
2015
Q3
$7.55M Buy
320,172
+15,752
+5% +$989K ﹤0.01% 2476
2015
Q2
$24.9M Buy
304,420
+99,232
+48% +$9.71M ﹤0.01% 1771
2015
Q1
$19M Buy
205,188
+118,358
+136% +$7.64M ﹤0.01% 1976
2014
Q4
$3.51M Buy
86,830
+16,481
+23% +$504K ﹤0.01% 2874
2014
Q3
$1.72M Sell
70,349
-3,176
-4% -$50.5K ﹤0.01% 3142
2014
Q2
$1.17M Sell
73,525
-1,040
-1% -$15K ﹤0.01% 3397
2014
Q1
$1.13M Sell
74,565
-18,628
-20% -$289K ﹤0.01% 3378
2013
Q4
$1.28M Buy
93,193
+13,420
+17% +$195K ﹤0.01% 3321
2013
Q3
$1.5M Buy
+79,773
New +$1.34M ﹤0.01% 3243

Other funds holding ESPR